Pen Needles Market Size is valued at USD 1.66 Bn in 2024 and is predicted to reach USD 3.43 Bn by the year 2031 at a 10.95% CAGR during the forecast period for 2024-2031.
Pen needle devices are available in a variety of lengths to fit different depths of subcutaneous tissue beneath the skin's surface. Pen needles are intended for single-use subcutaneous injection of medication and should not be reused. Diabetes is becoming more common, which has increased the demand for pen needles. With the expanding diabetic population, the target market is likely to increase at a rapid pace over the forecast period. Diabetic patients regularly utilize pen injectors to inject insulin or other medications. Obesity is among the major factors for diabetes, accounting for 80-85% of the chance of having the disease, according to Diabetes.co.uk. Insulin pens are the most simple and quick way to administer the medicine. Pen needles are in huge demand, in tandem with the increased need for insulin pens for diabetics.
Technological advances in various product kinds are also expected to support the growth of the pen needles business. Companies are concentrating on new product development in terms of needle length. For example, in 2021, BD (Becton, Dickinson, and Company) introduced the BD Nano Ultra-Fine pen needle, which has a needle length of 4 mm for increased patient comfort and consistent insulin delivery.
The Pen Needles market has been segmented based on time, length, therapy, and mode of purchase. The market is segmented as standard pen needles and safety pen needles based on type. The length segment includes 4 mm, 5 mm, 6mm, 8mm, and 10 mm. The therapy segment includes insulin, GLP 1, growth hormone, and other therapies. By the mode of purchase, the market is bifurcated as retail and non-retail.
Since diabetes individuals use bigger dosages daily, standard pen needles were recognized as the largest category. These needles are used by patients having dexterity issues. However, because there is a considerable danger of creating needlestick injuries, which restricts the safe applicability of pen needles, demand for these needles is expected to fall over the projection period.
The 8mm pen needle accounted for a sizable market share. These needles are most usually recommended to all patients, including those who are overweight and have the target condition. It provides benefits such as security, user convenience, and ease of disposal.
Due to the increasing frequency of the target condition in this region, Europe dominated the market. Furthermore, the government of the United Kingdom is taking majors to invest in diabetes care & research to improve treatment procedures for diabetic people. The growing number of diabetes patients in this region is fundamentally driving market growth in the United Kingdom. Diabetes, for example, affects more than 4.3 Bn individuals in the United Kingdom, according to Diabetes UK. Furthermore, 850,000 people with diabetes may go undetected.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 1.66 Bn |
|
Revenue Forecast In 2031 |
USD 3.43 Bn |
|
Growth Rate CAGR |
CAGR of 10.95% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, Technology, Application, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), Owen Mumford (UK), Terumo Corporation (Japan), Nipro Corporation (Japan) Allison Medical (US), AdvaCare Pharma (US), Berpu Medical Technology (China), ARKRAY (Japan), GlucoRx (UK), HTL-STREFA (Poland), UltiMed, (US), Hindustan Syringes and Medical Devices (India), Artsana Group (Italy), PromiseMed Diabetes Care (Canada), Montmed (Canada), Trividia Health (US), VOGT Medical Vertrieb (Germany), Van Heek Medical (Netherlands), Simple Diagnostics (US), Lyon (Turkey), Links Medical Products (US), and MHC Medical Products (US). |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Pen Needles Market Snapshot
Chapter 4. Global Pen Needles Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Product Type:
5.2.1. Standard pen needles
5.2.2. Safety pen needles
Chapter 6. Market Segmentation 2: By Length Estimates & Trend Analysis
6.1. By Length & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Length:
6.2.1. 4mm
6.2.2. 5mm
6.2.3. 6mm
6.2.4. 8mm
6.2.5. 10mm
6.2.6. 12mm
Chapter 7. Market Segmentation 3: By Mode of Purchase Estimates & Trend Analysis
7.1. By Mode of Purchase & Market Share, 2019-2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Mode of Purchase:
7.2.1. Retail
7.2.2. Non-retail
Chapter 8. Market Segmentation 4: By Therapy Estimates & Trend Analysis
8.1. By Product Type & Market Share, 2019-2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Therapy:
8.2.1. Insulin therapy
8.2.2. Glucagon-like Peptide-1 (GLP-1) therapy
8.2.3. Growth hormone therapy
8.2.4. Other therapies
Chapter 9. Pen Needles Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Pen Needles Market revenue (US$ Million) estimates and forecasts By Product Type, 2023-2031
9.1.2. North America Pen Needles Market revenue (US$ Million) estimates and forecasts By Length, 2023-2031
9.1.3. North America Pen Needles Market revenue (US$ Million) estimates and forecasts By Mode of Purchase, 2023-2031
9.1.4. North America Pen Needles Market revenue (US$ Million) estimates and forecasts By Therapy, 2023-2031
9.1.5. North America Pen Needles Market revenue (US$ Million) estimates and forecasts By country, 2023-2031
9.1.5.1. U.S.
9.1.6. Canada
9.2. Europe
9.2.1. Europe Pen Needles Market revenue (US$ Million) By Product Type, 2023-2031
9.2.2. Europe Pen Needles Market revenue (US$ Million) estimates and forecasts By Length, 2023-2031
9.2.3. Europe Pen Needles Market revenue (US$ Million) estimates and forecasts By Mode of Purchase, 2023-2031
9.2.4. Europe Pen Needles Market revenue (US$ Million) estimates and forecasts By Therapy, 2023-2031
9.2.5. Europe Pen Needles Market revenue (US$ Million) By country, 2023-2031
9.2.5.1. Germany
9.2.5.2. Poland
9.2.5.3. France
9.2.5.4. Italy
9.2.5.5. Spain
9.2.5.6. UK
9.2.5.7. Rest of Europe
9.3. Asia Pacific
9.3.1. Asia Pacific Pen Needles Market revenue (US$ Million) By Product Type, 2023-2031
9.3.2. Asia Pacific Pen Needles Market revenue (US$ Million) estimates and forecasts By Length, 2023-2031
9.3.3. Asia Pacific Pen Needles Market revenue (US$ Million) estimates and forecasts By Mode of Purchase, 2023-2031
9.3.4. Asia Pacific Pen Needles Market revenue (US$ Million) estimates and forecasts By Therapy, 2023-2031
9.3.5. Asia Pacific Pen Needles Market revenue (US$ Million) By country, 2023-2031
9.3.5.1. China
9.3.5.2. India
9.3.5.3. Japan
9.3.5.4. Australia
9.3.5.5. Rest of Asia Pacific
9.4. Latin America
9.4.1. Latin America Pen Needles Market revenue (US$ Million) By Product Type, 2023-2031
9.4.2. Latin America Pen Needles Market revenue (US$ Million) estimates and forecasts By Length, 2023-2031
9.4.3. Latin America Pen Needles Market revenue (US$ Million) estimates and forecasts By Mode of Purchase, 2023-2031
9.4.4. Latin America Pen Needles Market revenue (US$ Million) estimates and forecasts By Therapy, 2023-2031
9.4.5. Latin America Pen Needles Market revenue (US$ Million) By country, (US$ Million) 2023-2031
9.4.5.1. Brazil
9.4.5.2. Rest of Latin America
9.5. Middle East & Africa
9.5.1. Middle East & Africa Pen Needles Market revenue (US$ Million) By Product Type, (US$ Million)
9.5.2. Middle East & Africa Pen Needles Market revenue (US$ Million) estimates and forecasts By Length, 2023-2031
9.5.3. Middle East & Africa Pen Needles Market revenue (US$ Million) estimates and forecasts By Mode of Purchase, 2023-2031
9.5.4. Middle East & Africa Pen Needles Market revenue (US$ Million) estimates and forecasts By Therapy, 2023-2031
9.5.5. Middle East & Africa Pen Needles Market revenue (US$ Million) By country, (US$ Million) 2023-2031
9.5.5.1. South Africa
9.5.5.2. GCC Countries
9.5.5.3. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Becton, Dickinson and Company (US)
10.2.2. Novo Nordisk A/S (Denmark)
10.2.3. Ypsomed Holding AG (Switzerland)
10.2.4. B. Braun Melsungen AG (Germany)
10.2.5. Owen Mumford (UK)
10.2.6. Terumo Corporation (Japan)
10.2.7. Nipro Corporation (Japan) Allison Medical (US)
10.2.8. AdvaCare Pharma (US)
10.2.9. Berpu Medical Technology (China)
10.2.10. ARKRAY (Japan), GlucoRx (UK)
10.2.11. HTL-STREFA (Poland)
10.2.12. UltiMed, (US)
10.2.13. Hindustan Syringes and Medical Devices (India)
10.2.14. Artsana Group (Italy)
10.2.15. PromiseMed Diabetes Care (Canada)
10.2.16. Montmed (Canada)
10.2.17. Trividia Health (US)
10.2.18. VOGT Medical Vertrieb (Germany)
10.2.19. Van Heek Medical (Netherlands)
10.2.20. Simple Diagnostics (US)
10.2.21. Iyon (Turkey)
10.2.22. Links Medical Products (US)
Pen Needles Market By Type-
Pen Needles Market By Length-
Pen Needles Market By Mode of Purchase-
Pen Needles Market By Therapy-
Pen Needles Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
